Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2014

View Archived Issues

R-Tech Ueno completes phase I/II study of RU-101 for severe dry eye

ArQule collaborates with NIH on development of ARQ-092 in Proteus syndrome

VaxInnate reports topline results from phase I study of quadrivalent influenza vaccine candidate

Daiichi Sankyo selects research collaborations for 2014 TaNeDS drug discovery initiative

Novel anti-PD-L1 therapy shows promise in in vitro and in vivo bladder tumor models

OncoEthix updates on OTX-015 clinical trial program

Intarcia and Servier partner on ITCA-650 outside U.S. and Japan

Alios BioPharma presents preclinical data for novel nucleoside HCV polymerase inhibitors

ScinoPharm and Nanjing King-friend collaborate on Chinese development of regadenoson

GC-021109 receives FDA fast track designation

The Duchenne Alliance provides funds for follistatin gene therapy trial

Novel GPR119 agonists disclosed by Yuhan Corp.

AbbVie prepares new anti-RSV thiazoles

Matinas BioPharma begins dosing in first-in-human trial of MAT-9001

Phase III results presented for liraglutide as weight management drug in adults with obesity

HEP-114 dose-dependently improves liver function in patients with toxic-induced liver injury

E.U. orphan drug designation given to Xeris' soluble glucagon

NNZ-2566 shows clinical benefit phase II Rett syndrome trial

GlaxoSmithKline submits variation to the MAA for Revolade

Boehringer Ingelheim decides not to exercise option for Athera cardiovascular antibody

Highland Therapeutics reports topline data from phase III trial of HLD-200

Phase II SBIR grant supports ONL Therapeutics' development of ONL-101 in retinal detachment

Isis and AstraZeneca to collaborate on targeted delivery of antisense oligonucleotides

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...